OMEGA THERAPEUTICS INC's ticker is and the CUSIP is 68217N105. A total of 56 filers reported holding OMEGA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.77 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,993,120 | -61.6% | 1,857,265 | -0.1% | 0.01% | -58.6% |
| Q2 2023 | $10,411,324 | -7.0% | 1,859,165 | +0.1% | 0.03% | -12.1% |
| Q1 2023 | $11,199,308 | +5.6% | 1,857,265 | 0.0% | 0.03% | -2.9% |
| Q4 2022 | $10,604,983 | +5.4% | 1,857,265 | 0.0% | 0.03% | +6.2% |
| Q3 2022 | $10,066,000 | +42.6% | 1,857,265 | 0.0% | 0.03% | +77.8% |
| Q2 2022 | $7,058,000 | -39.1% | 1,857,265 | 0.0% | 0.02% | -25.0% |
| Q1 2022 | $11,589,000 | -44.9% | 1,857,265 | 0.0% | 0.02% | -41.5% |
| Q4 2021 | $21,043,000 | +374.5% | 1,857,265 | +689.3% | 0.04% | +355.6% |
| Q3 2021 | $4,435,000 | – | 235,294 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 25,902,269 | $98,428,000 | 3.71% |
| HARBOURVEST PARTNERS LLC | 2,647,059 | $10,059,000 | 3.30% |
| 72 Investment Holdings, LLC | 352,941 | $1,341,000 | 2.07% |
| CHI Advisors LLC | 1,055,882 | $4,012,000 | 1.53% |
| Artal Group S.A. | 2,273,530 | $8,639,000 | 0.46% |
| Oasis Management Co Ltd. | 160,000 | $608,000 | 0.11% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 694,431 | $2,639,000 | 0.10% |
| Laurion Capital Management LP | 432,700 | $1,644,000 | 0.02% |
| RBF Capital, LLC | 77,307 | $294,000 | 0.02% |
| STATE OF WISCONSIN INVESTMENT BOARD | 1,857,265 | $7,058,000 | 0.02% |